Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer, and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.

Quotes for Respiratorius AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Johan Drott

Chairperson of the Board

  • Karin Wehlin

Board

  • Johan Drott
  • Kristina Drott
  • Mia Lundblad
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    Johan Drott CEO presenterar på Life Science Day 2019

    Johan Drott CEO, presenterar på Redeye Investor Forum - 10 sep

    Johan Drott, CEO Respiratorius

    Presentation Stora Aktiedagen Stockholm 2017-11-13

    Largest Owners

    Name Capital % Votes % Date
    Avanza Pension 8,57 8,57 2024-09-26
    Valcuria Holding AB 3,61 3,61 2024-09-26
    Hans Mandahl 1,96 1,96 2024-09-26
    Fenja Capital Partners A/S 1,84 1,84 2024-09-26
    Hartmut Wiese 1,45 1,45 2024-09-26
    Göran Lennart Rehn 1,37 1,37 2024-09-26
    Nicholas Peebo 1,10 1,10 2024-09-26
    Hans Harvig 0,99 0,99 2024-09-26
    Mattias Nilsson 0,95 0,95 2024-09-26
    Ulf Stahlin 0,94 0,94 2024-09-26
    ** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

    Insider trading

    *Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

    Key Numbers

    *Compiled data from Millistream

    Upcoming reports

    • 2025-02-11 Bokslutskommuniké 2024

    Annual reports, prospectus etc.